Intelligence Platform

Patents

Browse 263 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 7772200

iRNA agents targeted to the Rho-A gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7727970

Multiple promoter expression cassettes for simultaneous delivery of RNAi agents targeted t

Benitec, Inc. · Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7709456

Modulation of gene expression by oligomers targeted to chromosomal DNA

The Board of Regents of the University of Texas System · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7662395

Method of enhancing a targeted immune response against tumors

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7611693

Mechanism-based targeted pancreatic beta cell imaging and therapy

The Board of Regents of the University of Texas System · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7579173

Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using th

The Board of Regents of the University of Oklahoma · Granted Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7541034

Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7479483

Tumor-targeted drug delivery systems and uses thereof

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7465716

Targeted drug delivery with a hyaluronan ligand

The Regents of the University of California · Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7371364

Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy

The Board of Regents of the University of Texas System · Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7368116

Method of enhancing a targeted immune response against tumors

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7354928

Small molecule inhibitors targeted at Bcl-2

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7267978

Chimeric transcriptional regulatory element compositions and methods for increasing prosta

The Regents of the University of California · Granted Tue Sep 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7223571

Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using sa

The Board of Regents of the University of Oklahoma · Granted Tue May 29 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6919425

Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targe

The Board of Regents of the University of Texas System · Granted Tue Jul 19 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6656917

Compositions and methods for targeted enzymatic release of cell regulatory compounds

Marker Gene Technologies, Inc · Granted Tue Dec 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6593308

Targeted drug delivery with a hyaluronan ligand

The Regents of the University of California · Granted Tue Jul 15 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6555367

Complex of biotinylated viral vector and ligand for targeted gene delivery

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6287562

Methods of inhibiting the growth of cells bearing LewisY antigens using B1, B3, or B5 targ

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6245747

Targeted site specific antisense oligodeoxynucleotide delivery method

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6217864

Method for targeted degradation of intracellular proteins in vivo or ex vivo

The Regents of the University of California · Granted Tue Apr 17 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6043082

Regulated transcription of targeted genes and other biological events

Board of Regents of the Leland Stanford Jr Univ · Granted Tue Mar 28 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6030954

Targeted delivery of poly- or oligonucleotides to cells

UNIVERSITY OF CONNECTICUT · Granted Tue Feb 29 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired